Peter Luo Amends Adagene Inc. Ownership Filing

Ticker: ADAG · Form: SC 13D/A · Filed: 2024-03-01T00:00:00.000Z

Sentiment: neutral

Topics: ownership-change, sec-filing, schedule-13d

Related Tickers: ADAG

TL;DR

Peter Luo updated his Adagene Inc. ownership filing on March 1st, related to an event on Jan 19th.

AI Summary

On March 1, 2024, Peter Luo filed an amendment (Amendment No. 2) to Schedule 13D for Adagene Inc. This filing indicates a change in beneficial ownership of Adagene Inc.'s ordinary shares. The filing was made as of March 1, 2024, with the date of the event requiring the filing being January 19, 2024.

Why It Matters

This filing signals a potential shift in control or significant stake changes for Adagene Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate significant strategic moves or potential takeovers, introducing uncertainty.

Key Numbers

Key Players & Entities

FAQ

What specific change in beneficial ownership is reported in this Amendment No. 2 to Schedule 13D?

The filing does not specify the exact change in beneficial ownership in the provided text, only that an amendment was filed due to an event on January 19, 2024.

Who is the authorized person to receive notices for this filing?

Peter Luo, located at Adagene, Inc., 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123, People's Republic of China, is authorized to receive notices.

What is the CUSIP number for Adagene Inc.'s ordinary shares?

The CUSIP number for Adagene Inc.'s ordinary shares is 005329 107.

What is the business address of Adagene Inc. as listed in the filing?

The business address is 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, F4, 00000.

Under which SEC Act and rule is this Schedule 13D/A filed?

This Schedule 13D/A is filed under the 1934 Act and Rule 13d-1(a) and amendments thereto filed pursuant to Rule 240.13d-2(a).

From the Filing

0001104659-24-030002.txt : 20240301 0001104659-24-030002.hdr.sgml : 20240301 20240301163020 ACCESSION NUMBER: 0001104659-24-030002 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 GROUP MEMBERS: HAN 2020 IRREVOCABLE TRUST SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adagene Inc. CENTRAL INDEX KEY: 0001818838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92270 FILM NUMBER: 24710403 BUSINESS ADDRESS: STREET 1: 4F, BUILDING C14, NO. 218, XINGHU STREET STREET 2: SUZHOU INDUSTRIAL PARK CITY: JIANGSU STATE: F4 ZIP: 00000 BUSINESS PHONE: 86-512-87773632 MAIL ADDRESS: STREET 1: 4F, BUILDING C14, NO. 218, XINGHU STREET STREET 2: SUZHOU INDUSTRIAL PARK CITY: JIANGSU STATE: F4 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Luo Peter CENTRAL INDEX KEY: 0001907614 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 10179 HUENNEKENS STREET SUITE 103 CITY: SAN DIEGO, STATE: CA ZIP: 92121 SC 13D/A 1 tm247478d1_sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)* Adagene, Inc. (Name of Issuer) Ordinary shares, par value USD $0.0001 per share (Title of Class of Securities) 005329 107** (CUSIP Number) Peter Luo Adagene, Inc. 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu Province, 215123 People’s Republic of China +86-512-8777-3632 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 19 , 2024 (Date of Event Which Requires the Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box:   ¨ Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP: 005329 107** Page 2 of  8 Pages 1 Names of reporting persons Peter Luo 2 Check the appropriate box if a member of a group (a) x         (b) ¨ 3 SEC use only 4 Source of funds PF; OO 5 Check if disclosure of legal proceedings is required pursuant to Item 2(d) or 2(e) x 6 Citizenship or place of organization United States Number of shares beneficially owned by each reporting person with 7 Sole Voting Power 12,008,498 (1) 8 Shared Voting Power 0 9 Sole Dispositive Power 3,245,439 (2) 10 Shared Dispositive Power 6,334,595 (3) 11 Aggregate Amount Beneficially Owned by Each Reporting Person 12,008,498 (1) 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨ 13 Percent of Class Represented by Amount in Row (11) 21.28% (4) 14 Type of Reporting Person IN (1)          Represents

View on Read The Filing